Embedding patient engagement in the R&D process of a life sciences company through co-creation with a patient expert R&D board: a case study.
Por:
Jobson, Estelle, Garcia, Marta, Sharek, Danika, Risueno, Laura, Arnould, Sylvain, Lemoine-Andre, Aude, Geissler, Jan, Amariutei, Ana, Grigolo, Sabrina, Nafria-Escalera B, Smith, Thomas, Sousa, Oriana, Stone, Linda and West, Janet
Publicada:
6 nov 2024
Resumen:
Patient involvement is crucial in healthcare, a factor increasingly
recognised by life sciences companies and research institutes. This
article presents a case study on Servier, a life sciences company that
founded a patient expert board, ahead of launching a new research and
development (R&D) institute. The aim was to foster a patient-centric
culture within the company. The case study explores key developments in
patient and public involvement, emphasising a shift from paternalistic
to patient-centred approaches, noting few available case studies on
patient board collaborations in life sciences. It outlines the evolution
of the board, its impact, and practical lessons learned, with related
recommendations. The patient board resulted from a three-way
collaboration between the company, Patvocates (a patient consultancy),
and patient experts recruited. The patient consultancy played a crucial
role in project management, governance, and facilitating relationships.
The case study provides the context, timeframe, foundations laid,
engagement of patient experts, and foundational values, including:
co-creation, fair market value remuneration, voluntary participation,
and patient-centric meeting protocol. Eighteen patient experts,
representing ten disease areas and ten European countries, joined the
board and helped prioritise and co-create projects. Ideas for activities
were sourced from brainstorming sessions and an in-company challenge.
The collaboration yielded five core ideas, each forming a working group.
The study describes the groups and their outputs: a patient advisory
council, an interactive gallery of patient experience in R&D, patient
engagement and entrepreneurship in life sciences, creating
patient-focused decentralised trials (DCTs), and staff training on
patient engagement. The article emphasises how the organic evolution of
the collaboration led to significant insights. Hurdles faced by the
company included: upstream planning, cross-company buy-in, compliance,
and internal resource allocation. Recommendations for the wider
community included: identifying and contracting patient partners;
clarifying roles; managing expectations; building trust; logistics; and
sustainability. This case study presents a practical, positive example
of patient engagement within a life sciences company, offering insights
into the establishing, running, and the impact of collaborating with a
patient expert board. Lessons learned and recommendations may serve as a
model for other companies seeking to engage with patients and evolve
towards a more patient-centric approach in their strategies.
Filiaciones:
EUPATI Fellow, Nyon, Switzerland.
Institut de Recherches Internationales Servier IRIS, Madrid, Spain
Patvocates, Munich, Germany
Institut de Recherches Internationales Servier IRIS, Paris, France
EUPATI Fellow, Munich, Germany
EUPATI Fellow, Trofarello, Italy
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
EUPATI Fellow, Marske, UK
EUPATI Fellow, Leiria, Portugal
Sjogren's UK (Previously British Sjogren's Syndrome Association),
Birmingham, UK
Independent Patient Expert, Hampshire, UK
|